Search research articles
Contact Us
Filters
Showing results (121-130 of 253) with videos related to
Page
of 26
Sort By:
Translational Cancer Research
|
December 19, 2024
Integrating artificial intelligence in renal cell carcinoma: evaluating ChatGPT's performance in educating patients and trainees
J Patrick Mershon, Tasha Posid, Keyan Salari, et al.
Journal of Cancer
|
May 17, 2013
Low Grade Micropapillary Urothelial Carcinoma, Does It Exist? - Analysis of Management and Outcomes from the Surveillance, Epidemiology and End Results (SEER) Database
Srinivas Vourganti, Andrew Harbin, Eric A Singer, et al.
Current Opinion in Oncology
|
March 28, 2012
Active surveillance for prostate cancer: past, present and future
Eric A Singer, Aradhana Kaushal, Baris Turkbey, et al.
Urologic Oncology
|
July 2, 2025
Concordance between clinical and pathologic staging of larger (cT2a-b) and more invasive (cT3a) renal cell carcinoma
Taylor Goodstein, Rajvi Goradia, Arnav Srivastava, et al.
Current Urology Reports
|
January 6, 2021
From Diagnosis to Therapy-PET Imaging for Pheochromocytomas and Paragangliomas
Hiren V Patel, Arnav Srivastava, Murray D Becker, et al.
Journal of Cancer Metastasis and Treatment
|
April 24, 2026
Perioperative therapies for metastatic renal cell carcinoma
Matthew P Lierz, Allen Enrique D Siapno, Adam Khorasanchi, et al.
European Urology
|
December 3, 2014
Response to crizotinib in a patient with MET-mutant papillary renal cell cancer after progression on tivantinib
Mark N Stein, Kim M Hirshfield, Hua Zhong, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
November 16, 2017
Androgen deprivation therapy for the treatment of prostate cancer: a focus on pharmacokinetics
Charles F Polotti, Christopher J Kim, Nadiya Chuchvara, et al.
Clinical Genitourinary Cancer
|
September 17, 2025
Impact of Upstaging From cT2a-b to pT3a on Overall Survival Among Patients With Renal Cell Carcinoma
Taylor Goodstein, Rajvi Goradia, Arnav Srivastava, et al.
Clinical Genitourinary Cancer
|
March 18, 2026
Retraction notice to " Impact of Upstaging From cT2a-b to pT3a on Overall Survival Among Patients With Renal Cell Carcinoma"[Clinical Genitourinary Cancer 23/6 (2025) 102422]
Taylor Goodstein, Rajvi Goradia, Arnav Srivastava, et al.
Page
of 26
Search research articles
Search
Showing results (121-130 of 253) with videos related to
Sort By:
Page
of 26
Translational Cancer Research
|
December 19, 2024
Integrating artificial intelligence in renal cell carcinoma: evaluating ChatGPT's performance in educating patients and trainees
J Patrick Mershon, Tasha Posid, Keyan Salari, et al.
Journal of Cancer
|
May 17, 2013
Low Grade Micropapillary Urothelial Carcinoma, Does It Exist? - Analysis of Management and Outcomes from the Surveillance, Epidemiology and End Results (SEER) Database
Srinivas Vourganti, Andrew Harbin, Eric A Singer, et al.
Current Opinion in Oncology
|
March 28, 2012
Active surveillance for prostate cancer: past, present and future
Eric A Singer, Aradhana Kaushal, Baris Turkbey, et al.
Urologic Oncology
|
July 2, 2025
Concordance between clinical and pathologic staging of larger (cT2a-b) and more invasive (cT3a) renal cell carcinoma
Taylor Goodstein, Rajvi Goradia, Arnav Srivastava, et al.
Current Urology Reports
|
January 6, 2021
From Diagnosis to Therapy-PET Imaging for Pheochromocytomas and Paragangliomas
Hiren V Patel, Arnav Srivastava, Murray D Becker, et al.
Journal of Cancer Metastasis and Treatment
|
April 24, 2026
Perioperative therapies for metastatic renal cell carcinoma
Matthew P Lierz, Allen Enrique D Siapno, Adam Khorasanchi, et al.
European Urology
|
December 3, 2014
Response to crizotinib in a patient with MET-mutant papillary renal cell cancer after progression on tivantinib
Mark N Stein, Kim M Hirshfield, Hua Zhong, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
November 16, 2017
Androgen deprivation therapy for the treatment of prostate cancer: a focus on pharmacokinetics
Charles F Polotti, Christopher J Kim, Nadiya Chuchvara, et al.
Clinical Genitourinary Cancer
|
September 17, 2025
Impact of Upstaging From cT2a-b to pT3a on Overall Survival Among Patients With Renal Cell Carcinoma
Taylor Goodstein, Rajvi Goradia, Arnav Srivastava, et al.
Clinical Genitourinary Cancer
|
March 18, 2026
Retraction notice to " Impact of Upstaging From cT2a-b to pT3a on Overall Survival Among Patients With Renal Cell Carcinoma"[Clinical Genitourinary Cancer 23/6 (2025) 102422]
Taylor Goodstein, Rajvi Goradia, Arnav Srivastava, et al.
Page
of 26